Adherence to oral chemotherapy: a review of the evidence
Intended for healthcare professionals
Art & Science Previous     Next

Adherence to oral chemotherapy: a review of the evidence

Gary Mitchell PhD student, Queen’s University Belfast
Sam Porter Professor and chair in nursing research, Queen’s University Belfast
Elizabeth Manias Professor, School of Nursing and Midwifery, Deakin University, Burwood, Victoria, Australia, Department of Medicine, Royal Melbourne Hospital, University of Melbourne

Gary Mitchell and colleagues examine concerns about the practice of oral chemotherapy administered by patients at home, and the importance of communication in ensuring concordance

Oncology is rapidly changing. Over the past few years there has been an increase in the number of patients receiving oral chemotherapy, which is often administered as tablets away from the hospital setting and in the absence of direct health professional support. This situation places onus on patients to not only administer their medication, but also to report any deterioration in their health. Medication adherence in oral chemotherapy is therefore a major concern. This article examines medication adherence for people receiving oral chemotherapy and the importance of concordant communication practices.

Cancer Nursing Practice. 13, 4, 25-28. doi: 10.7748/cnp2014.


Peer review

This article has been subject to double blind peer review

Conflict of interest

None declared

Received: 25 October 2013

Accepted: 07 April 2014

Want to read more?

Already subscribed? Log in


Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

Your subscription package includes:
  • Unlimited online access to all 10 RCNi Journals and their archives
  • Customisable dashboard featuring 200+ topics
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests
RCN student member? Try Nursing Standard Student

Alternatively, you can purchase access to this article for the next seven days. Buy now